Grufity logo
Grufity logo
BTTX

BTTX - Better Therapeutics, Inc. Stock Price, Fair Value and News

00
Market Closed as of 15 Jun 2026, 04:00 pm ET

Price Targets

BTTX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

BTTX Price Action

BTTX RSI Chart

BTTX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

BTTX Valuation

Market Cap

0

Price/Earnings (Trailing)

0

EV/EBITDA

-0.04

Price/Free Cashflow

0

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

BTTX Fundamentals

BTTX Earnings

BTTX Profitability

Free Cashflow Yield

0%

BTTX Investor Care

About Better Therapeutics, Inc.

BTTX
Better Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company's lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions. In addition, the company's clinical development candidates are intended to treat cardiometabolic diseases, including type 2 diabetes, hypertension, hyperlipidemia, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and chronic kidney disease. Its product pipeline also includes BT-002, which intends glycemic control for hypertension; BT-003 to reduce LDL cholesterol in patients with hyperlipidemia; and BT-004, which intends to explore the impact of treatment on liver health in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease. The company was founded in 2015 and is headquartered in San Francisco, California.
 CEO
 WEBSITEbettertx.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES54

Better Therapeutics, Inc. Frequently Asked Questions

BTTX is the stock ticker symbol of Better Therapeutics, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Thu May 28 2026, market cap of Better Therapeutics, Inc. is 0. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.